Browsing: Featured
Vivodyne and the Post-Animal-Testing Economy: How AI + Human Tissue Is Reshaping Drug Discovery
For roughly seventy years, the standard route from a promising drug candidate to a first-in-human trial has run through mice.…
GPT-6 Astra release: OpenAI’s frontier model outperforms every prior benchmark. Trained on 100,000+ GPUs, restricted cybersecurity access, $10/$50 per M tokens API pricing.
Longevity economy: $27B invested since 2020. Altos Labs, Retro Biosciences, Calico shaping the category. ARPA-H commits $2.5B.
ESG investing has reached a more sustainable equilibrium after the boom and backlash. The marketing category has receded; the substantive integration of environmental and social factors into investment has continued. Understanding the difference matters.
At 2:17 AM, somewhere in Singapore, a founder hits “Deploy.”There is no team Slack channel lighting up. No late-night engineering…
There is a scene playing out in offices across the world right now. A 26-year-old analyst sits across from a…
This article explores how the cybersecurity landscape is transforming, the trends defining its trajectory, and what the future holds for companies navigating this high-stakes domain.
78% of organizations say they use AI. 95% of their pilots aren’t generating real returns. Here’s the story underneath both numbers.